Justifying the source of external comparators in single-arm oncology health technology submissions: a review of NICE and PBAC assessments
Background: The drive to expedite patient access for diseases with high unmet treatment needs has come with an increasing use of single-arm trials (SATs), especially in oncology. However, the lack of control arms in such trials creates challenges to assess and demonstrate comparative efficacy. Ext...
Main Authors: | Katherine Appiah, Maria Rizzo, Grammati Sarri, Luis Hernandez |
---|---|
Format: | Article |
Language: | English |
Published: |
Becaris Publishing Limited
2024-01-01
|
Series: | Journal of Comparative Effectiveness Research |
Subjects: |
Similar Items
-
Navigating the unknown: how to best ‘reflect’ standard of care in indications without a dedicated treatment pathway in health technology assessment submissions
by: Grammati Sarri, et al.
Published: (2024-01-01) -
Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers
by: Kristian Thorlund, et al.
Published: (2024-03-01) -
External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigations
by: Patrick Silva, et al.
Published: (2023-07-01) -
Utilization of anonymization techniques to create an external control arm for clinical trial data
by: Juha Mehtälä, et al.
Published: (2023-11-01) -
Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations
by: W. Katherine Tan, et al.
Published: (2022-12-01)